Vimarsana
Biggest News Aggregation in the World

Page 32 - Ace2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ace2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ace2 Today - Breaking & Trending Today

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2 - Vimarsana News

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2

A team of researchers from Spain and Canada recently characterized the antibody kinetics and neutralization capacity at 4 cross-sectional surveys between March and October 2020 and determined the seroprevalence in the same cohort of healthcare workers.

Study explains the evolution of SARS-CoV-2 virus - Vimarsana News

Study explains the evolution of SARS-CoV-2 virus

Study explains the evolution of SARS-CoV-2 virus As COVID-19 sweeps the world, related viruses quietly circulate among wild animals. A new study shows how SARS-CoV-2, the virus that causes COVID-19, and SARS-CoV-1, which caused the 2003 SARS outbreak, are related to each other. The work, published recently in the journal Virus Evolution, helps scientists better understand the evolution of these viruses, how they acquired the ability to infect humans and which other viruses may be poised for human spillover. How did these viruses come to be what they are today? Why do some of them have the ab...

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective - Vimarsana News

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

SARS-CoV-2 does not infect the entire body in the same way, finds study - Vimarsana News

SARS-CoV-2 does not infect the entire body in the same way, finds study

COVID-19, the disease caused by the pandemic coronavirus SARS-CoV-2, is primarily regarded as a respiratory infection. Yet the virus has also become known for affecting other parts of the body in ways not as well understood, sometimes with longer-term consequences, such as heart arrhythmia, fatigue and "brain fog."

High expression of ACE2 receptors in developing ovaries increases SARS-CoV-2 risk - Vimarsana News

High expression of ACE2 receptors in developing ovaries increases SARS-CoV-2 risk

A team of scientists from China collaborated to find if SARS-CoV-2 could also infect the ovary at different developmental stages.